Bloomberg Intelligence cover image

Hunter Biden, Eli Lilly, CAVA, and Geopolitics (Podcast)

Bloomberg Intelligence

00:00

Dice: A New Therapeutic Approach to Treating Dermatological Disease

Paul Sweeney: Another deal for Lily, $2.4 billion for immune drug developer Dice. Sam Visela says big pharma companies are really active on the M&A front buying drugs and therapies. The company is acquiring a novel therapeutic approach to treating dermatological disease. We'll check in with Sam about his side business as an analyst for Bloomberg Intelligence.

Play episode from 07:08
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app